Mirador Therapeutics
Developing precision medicines for immunology and inflammation diseases
Company facts
- Founded
- 2024
- Employees
- 105
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $250M · 2025
Developing precision medicines for immunology and inflammation diseases
Company facts